The nNOS-p38MAPK Pathway Is Mediated by NOS1AP during Neuronal Death

dc.contributor.authorLi L
dc.contributor.authorGinet V
dc.contributor.authorLiu X
dc.contributor.authorVergun O
dc.contributor.authorTuittila M
dc.contributor.authorMathieu M
dc.contributor.authorBonny C
dc.contributor.authorPuyal J
dc.contributor.authorTruttmann AC
dc.contributor.authorCourtney MJ
dc.contributor.organizationfi=JBL-laboratorio|en=Joint Biotechnology Laboratory (JBL)|
dc.contributor.organizationfi=Turun biotiedekeskus|en=Turku Bioscience Centre|
dc.contributor.organization-code1.2.246.10.2458963.20.18586209670
dc.contributor.organization-code1.2.246.10.2458963.20.53708885453
dc.converis.publication-id1925852
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/1925852
dc.date.accessioned2022-10-28T14:01:26Z
dc.date.available2022-10-28T14:01:26Z
dc.description.abstractNeuronal nitric oxide synthase ( nNOS) and p38MAPK are strongly implicated in excitotoxicity, a mechanism common to many neuro-degenerative conditions, but the intermediary mechanism is unclear. NOS1AP is encoded by a gene recently associated with sudden cardiac death, diabetes-associated complications, and schizophrenia (Arking et al., 2006; Becker et al., 2008; Brzustowicz, 2008; Lehtinen et al., 2008). Here we find it interacts with p38MAPK-activating kinase MKK3. Excitotoxic stimulus induces recruitment of NOS1AP to nNOS in rat cortical neuron culture. Excitotoxic activation of p38MAPK and subsequent neuronal death are reduced by competing with the nNOS: NOS1AP interaction and by knockdown with NOS1AP-targeting siRNAs. We designed a cell-permeable peptide that competes for the unique PDZ domain of nNOS that interacts with NOS1AP. This peptide inhibits NMDA-induced recruitment of NOS1AP to nNOS and in vivo in rat, doubles surviving tissue in a severe model of neonatal hypoxia-ischemia, a major cause of neonatal death and pediatric disability. The highly unusual sequence specificity of the nNOS: NOS1AP interaction and involvement in excitotoxic signaling may provide future opportunities for generation of neuroprotectants with high specificity.
dc.format.pagerange8185
dc.format.pagerange8201
dc.identifier.eissn1529-2401
dc.identifier.jour-issn0270-6474
dc.identifier.olddbid185796
dc.identifier.oldhandle10024/168890
dc.identifier.urihttps://www.utupub.fi/handle/11111/52473
dc.identifier.urnURN:NBN:fi-fe2021042714357
dc.language.isoen
dc.okm.affiliatedauthorTuittila, Minna
dc.okm.affiliatedauthorCourtney, Michael
dc.okm.discipline1182 Biochemistry, cell and molecular biologyen_GB
dc.okm.discipline3111 Biomedicineen_GB
dc.okm.discipline1182 Biokemia, solu- ja molekyylibiologiafi_FI
dc.okm.discipline3111 Biolääketieteetfi_FI
dc.okm.internationalcopublicationinternational co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisherSOC NEUROSCIENCE
dc.publisher.countryUnited Statesen_GB
dc.publisher.countryYhdysvallat (USA)fi_FI
dc.publisher.country-codeUS
dc.relation.doi10.1523/JNEUROSCI.4578-12.2013
dc.relation.ispartofjournalJournal of Neuroscience
dc.relation.issue19
dc.relation.volume33
dc.source.identifierhttps://www.utupub.fi/handle/10024/168890
dc.titleThe nNOS-p38MAPK Pathway Is Mediated by NOS1AP during Neuronal Death
dc.year.issued2013

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
2013_NOS1AP JNSC.pdf
Size:
3.82 MB
Format:
Adobe Portable Document Format
Description:
Publisher's PDF